Protest Letter Urges Closure of E-Cigarette Store in Otani

Regulations by 2FIRSTS.ai
Dec.19.2023
Protest Letter Urges Closure of E-Cigarette Store in Otani
Residents of Otane, New Zealand, have submitted a protest against the establishment of an e-cigarette store in their town.

According to a report by nzherald, Kerry Low, a resident of Otani in New Zealand, has submitted a letter of protest to the Mayor of Whakatane, Alex Walker, opposing the establishment of an e-cigarette store in Otani. The Otani community has taken steps to prevent the sale of e-cigarette products in their town.

 

The Otani Community in the San Hu Ke Bay Area received a petition signed by 502 individuals opposing the establishment of an e-cigarette shop in the town and calling for its closure. Otani resident Kerry Low, after seeking advice, handed over the petition to the mayor, expressing concerns about the sale of e-cigarette products in town and their impact on the local youth.

 

Mayor Alex Walker stated that the local council has made decisions regarding the sale and supply of alcohol after consulting with the community, but they do not have the authority to regulate the sale of e-cigarette products in the same manner. However, they do have a legal obligation to promote community well-being and have the capability to provide valuable local context and knowledge.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Singapore man, 21, assisting investigations after video allegedly shows him vaping on a bus
Singapore man, 21, assisting investigations after video allegedly shows him vaping on a bus
A 21-year-old man in Singapore is assisting with investigations after a video allegedly showing him vaping inside a bus went viral on social media. The Health Sciences Authority (HSA) said via its Instagram Stories that it had identified the man and seized e-vaporisers and 12 pods from his home on Feb 3. Vape-related penalties were strengthened from Sept 1, with first-time adult users liable to a $700 fine, and third-time offenders prosecuted and fined up to $2,000.
Feb.06
Kardinal to Launch Dual Open-System Devices Globally in Q1 2026
Kardinal to Launch Dual Open-System Devices Globally in Q1 2026
Kardinal OS and Syn Signal Strategic Expansion in Open-System ENDS
Dec.31
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore will maintain etomidate’s classification under drug control laws while preparing new legislation targeting e-vaporisers, as authorities reinforce a hardline regulatory stance on vaping.
Feb.05
China Tobacco Annual Meeting Flags “New Growth Drivers” for 2026: Cigarette Innovation, Domestic Cigars, Overseas Business and Multi-Purpose Use
China Tobacco Annual Meeting Flags “New Growth Drivers” for 2026: Cigarette Innovation, Domestic Cigars, Overseas Business and Multi-Purpose Use
China’s tobacco authorities used their annual industry meeting in Beijing to outline new growth drivers for 2026, highlighting cigarette innovation, domestic cigars, overseas business expansion and multi-purpose tobacco applications.
Special Report
Jan.20
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International: Over $20 Billion Invested in the U.S. Since 2022; IQOS ILUMA to Launch Pending FDA Authorization
Philip Morris International (PMI) said its U.S.-related investments have topped $20 billion since 2022, when it entered the U.S. market through its roughly $19 billion acquisition of Swedish Match. The company also said it plans to launch its heated tobacco product IQOS ILUMA in the United States pending authorization from the U.S. Food and Drug Administration (FDA).
Jan.16 by 2FIRSTS.ai